O-001 O-002 O-003 O-004 O-005 O-006 O-007 O-008
|
|
|
- ゆき やすこ
- 7 years ago
- Views:
Transcription
1 é
2 O-001 O-002 O-003 O-004 O-005 O-006 O-007 O-008
3 O-009 O-010 O O-012 O-013 O-014 O-015 O-016 O O-018 VII1 O-019 O-020 O-021 O-022 O-023 O-024 1
4 P-001 P-002 P-003 P-004 P-005 P-006 P-007 P-008 P-009 P-010 P-011 P-012 P-013 P-014 P-015 P-016 P-017 P-018 P-019
5 P-020 P-021 P-022 P-023 P-024 IGFBP-1 P-025 P-026 P-027 P-028 P-029 P P-031 P-032 P-033 P-034 P-035 P-036 P-037 P-038 P-039 P-040 P-041 P-042 P-043 P-044 P-045 P-046 P-047 P-048 P-049 P P-051 P-052 P-053 P-054 MRSAMycotic aneurysm
6 P-055 P-056 P-057 P-058 P-059 P-060 P kg P-062 P-063 P-064 P-071 P-072 P-073 P-074 P-075 P-076 P-077 P-078 P-079 P-080 amniotic sheets 1 P P-066 P-067 P-068 P-069 P-070 P-081 P-082 P-083 P-084 P-085 P-086 P-087 P-088
7 P-089 P-090 P-091 P-092 P-093 P-094 P-095 P-096 P-097 P-098 P-099 P-100 P-101 NICU P P P P-105 P P-107 P-108 P-109 P-110 P-111 P P-113 NICU P-114 NICU2 P-115 P-116 P P-118 NICU P P-120 NMCS NMCS P-121 P-122 NICU 2 P-123 ADHD P-124 P-125 DHA EPA
8 P P-127 Pelizaeus-Merzbacher P-128 Halo scalp ring P P P-131 Hirschsprung P-132 MMI2 P-133 P P P P P-138 Facio-aucurio-vertebral spectrum 1 Goldenhar MM P-139 3PCS Premature Chromatid Separation P-140 Noonan P-141 3q trisomy NICU P-142 Type I IgE P P-144 West P-145 P P q13 P-148 Toriello-Carey 1 P-149 Sotos 1 P P P-152 P-153 Mesodiverticular band 1 P-154 S 1 P P-156 CCAM 3 P P P P P-161 Sengstarken-Breakmore Tube S-B tube1
9 O-025 O O O-028 Klippel-Trenaunay KTS 1 O O-030 GDM O O-032 O-033 O Basedow 1 O-035 O O-037 rapid tocolysis O-038 O-039 VBAC O-040 VBAC O-041 O CDH O-043 ECMO O-044 NO PGE1 vs NO O-045 ECMO O-046 ECMO 11 O-047 MRI O-048 MRI O-049 O-050 O-051 O-052
10 O-053 Bochdaleck O O-055 O-056 O-057 O-058 NICU O-059 AGA SGA O-060 O NICU O-070 O O-072 NICU IgE O O O-075 O-076 O-077 O-078 O-061 O O-063 CHDF O-064 O-065 Very low density lipoprotein VLDL O-066 IGF-1 O O-080 DORV1 O-081 O-082 O O-084 SS-A O-067 BFH O-068 Hold pressure O-085 O-086
11 O O-088 O-089 O-090 NICU O MRI O O-093 TTTS O-094 O-095 O O O098 Stress-Velocity O-099 3D VLBW Stress-Velocity O-100 NT-proBNP O-101 N-terminal probnp NT-proBNP O-102 O-103 NICU NICU O PDA O-105 O-106 O-107 O-108 O-109 IGF-1 O-110 O-111 RetCam 1 O SGA AGA O-113 O-114 O O FMNN O-117 NICU O-118 O-119 O-120
12 O g 3 O-122 O-123 NICU 24 O O O-126 O-127 vascular access O-128 O g2 O-130 PICC NICU O-131 O CMV fetal palliative care Late Preterm Birth LPB 2 Late preterm 3 4 Late-preterm 5late preterm
13 NICU ml 4 NICU VBAC O-133 O-134 Coiling index O-135 pulsation O-136 O-137 Amniotic sheet 1 O NRFS 1 2 3UAE 4 cesarean hysterectomy 5 O-139 O-140 O-141 O-142 O O-144 O-146 O O-148 O-149
14 O-150 IUGR O-151 O-152 Preeclampsia O-153 O-168 CATCH22 1 O O-170 O O-154 L- + h O-155 Th1/Th2 O-156 Reversible Posterior Leukoencephalopathy Syndrome 2 O-157 PIH IUGR O-158 O-159 IUGR cerebroplacental ratio CTG O-172 NST O O O-175 O O-177 persistent cloaca 1 O-160 IUGR O-161 IUGR O-162 O-163 O-164 SGA O-165 severe IUGR O-166 O O O-179 O O-181 O O-183 O-184 O-185 3D
15 O-186 3DCT1 P P-163 P-164 P-165 P-166 Breus` mole P-167 P-168 P P P-171 P P-173 MRI4 P-174 P P P P-178 P-179 CPAP P-180 CPAP 1 P P-182 P-183 P P-185 P-186 P-187 E P P-189 Rh P-190 ITP Upshaw-Schulman 1 P-191 Klippel-Trenaunay-Weber P-192 P-193 P-194 1
16 P-195 P P P-198 S 1 P P-200 Jr a 1 P-201 Light for gestational age infant P-202 P-203 P-204 P-205 P-206 P P P-209 ME P P-211 P-212 P-213 P P-215 NMCS P-216 RSV P-217 NICU PIMS P-218 P-219 NICU P NICU P-221 P-222 P-223 venous angioma P P P-226
17 P P-228 Neonatal Hyperekplexia P-229 P-230 P-231 PVLMRI P-232 DHA P-233 CT P-234 NICU P P-236 PI P P-238 P-239 High CSF Antioxidants and IL8 are protective of Hypoxic Brain Damage in Newborns Hussein Mohamed P-240 HIE Begum Esmot Ara P P-242 NICU P-243 Late-Preterm HIE 3 Term P P P-246 NICU6 P-247 HPA-4b 1 P-248 NICU NITP P P-250 Upshaw-Schulman 1 P-251 A P-252 A 2 P-253 P-254 P-255 TAM 2 P-256 band3 2 P-257 P P-259 glomerulocystic kidney disease 1 P-260 HMGB-1 P P-262 NICU Streptococcus bovis
18 P-263 MRSA18 MRSA P RS P-265 HIV-1 25 P-266 HIV 3 P P P P F-fluoro-L-DOPA PET P-271 P-272 P-273 P-274 P-275 P-276 Gaucher 1 P P P P-280 5b TRACP-5b P P-282 DIC P P P P P P P-289 valve bladder 1 P-290 Potter sequence 1 P-291 P-292 rt-paelbw 1 P P
19 O-187 O-188 Viral-Associated Hemophagocytic Syndrome 1 O HCV-RNA HCV O-190 -T ParvovirusB19 O O-192 IgG avidity PCR NTT O-193 O-194 O-195 O-196 O-197 O-198 RPLS O-199 XY O-200 O-201 O-202 O O-204 O O-206 O-207 O-208 2nd trimester 2 O-209 MFICU O-210 MgSO4 O-211 RCT MGS O-212 O-213 O-214 O-215 O-216 MFICU 32 O-217
20 O O preterm PROM O O-221 Selective IUGR TTTS O-222 O-223 MD O-224 TTTS normal-polyhydramnios13 O-225 TTTS O O-227 MD O-228 TRAP sequence RFA O-229 Selective IUGR O-230 O-231 O-232 O O-234 O-235 NT Nuchal translucency O-236 O-237 X cell-free fetal DNA O-238 O-239 O-240 O-241 NICU aeeg O-242 O-243 O-244 O-245 O-246 IL-6 O-247 O MRI O-249 MRI 1 61 O-250 MRI 1 62 O-251 MRI
21 O-252 O-270 HCV14 prospective study O-253 O-254 NIRS O-255 Microdialysis O-256 O-257 O-258 O Palivizumab O-260 RS DIC O-261 NICU O O-263 APR O-264 O-265 Bifidobacterium bifidum O-266 antimicrobial peptides O-267 O O-269 HIV O O-272 O-273 O-274 O O-276 O-277 O O O-280 CD Clostridium difficile O O O-283 CO O-284 Total Bilirubin O-285 UB
22 O-286 LED O-287 LED O-304 NICU O-305 O-288 Bernard-Soulier 1 O-289 Hb1.8g/dl 1 O-290 C O-291 O-292 rhg-csf O O O-307 CLD3 O O O-310 DCH CLD O-311 O O O O O-298 IGF2-H19 O-299 Campomelic dysplasia 14 SOX9 O NO1 O-313 NO Epoprostenol Sildenafil O-314 NICU O-315 NRPSpO2 O SpO2 O-317 KL-6 D SP-D O-300 O-301 HFO 3 O O-303
教室業績2014
MFICU MFICU : - : - : -,,, : - : -- - : - : - : - - - : - - - - : - : - : - : -, : - Takano Y, Furukawa S, Ohashi M, Michikata K, Sameshima H, Ikenoue T J Obstet Gynaecol Res, : -, CTG - CTG - : - Katsuragi
2011 2014 19 22-1 - - 2 - - 3 - - 4 - HIV HIV - 5 - SCU - 6 - ICUHCU NICU NICU HCU NICU ALSO - 7 - T-MRI FISH - 8 - ME NST - 9 - - 10 - da Vinci C C C DPC - 11 - C C C C C C - 12 - C C D D DPC D D - 13
2015 3 1.... 1 2.... 2 (1)... 2... 2... 3... 4 (2)... 5... 5... 6 (3)... 7 DPC... 7... 8 3.... 11 (1)... 11... 11... 12... 14 (2)... 15... 15... 16 (3)... 17... 17... 17 4.... 19 (1)... 19 (2) SWOT...
Professor Emeritus of Surgery, The University of Iowa College of Medicine Ken Kimura
51 3 2015 5 351 52 1 5 28 1 8 55 9 00 9 00 10 30 1 Keynote Lecture RS1-1 RS1-2 RS1-3S OCIAD2 DNA I RS1-4 Kif26A KO RS1-5 RS1-6S TLR-4 IL-4 DEC205 RS1-7S PGE-MUM 10 30 11 20 1 OS1-1 MAPK in vitro OS1-2
無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
教室業績2014
p- p- p- p- : - N-N : - : - : - - : - : - : - : - Katakami H, Hashida S, Oki Y, Murakami O, Ikenoue T, Ono H, Matsukura S Clin Pediatr Endocrinol, suppl : -,. Ochiai H, Ikeda T, Mishima K, Yoshikawa T,
04_ポスター.indb
般ポスター基礎超音波計測一般 一般ポスター基礎 6 月 8 日 ( 金 ):00 - :0 ポスター会場 ( 神戸ポートピアホテル B F 座長 : 9- 基 P-00 S790 9- 基 P-00 S790 9- 基 P-00 S79 Jing ZHU, 9- 基 P-00 S79 9- 基 P-005 S79 9- 基 P-006 CT S79 Wenjing WU 9- 基 P-007 HIFU
2006年3月8日
18 21 1990 2004 2 2005 14 15 2004 1990 2005 2003 300 7 2 1 2005 1972 100 40 6 1972 2004 197 6,500 2004 21 59 100 65 2007 5 2005 30 1.8 535.89 348.33 187.56 2006 2006 5 1 30 1 30 46 46 1 46 1000kl 4 1 100kl
QOL 02 QOL QOL UI AI EAThoracotomy TTThoracoscopy TS QOL EA type-c y score UI 3 AI 8 School score QOL score 12
54 1 2018 2 4-1 OK-432 1 15 14 15 US CT MRI 17 cm 0.16 g/kg/day OK-432 3 1 ke 2 2 ke 3 1 1,150 ml 13 US OK-432 4-2 TJ-28 TJ-28 2003 3 2017 6 250 TJ-28 44 16 28 TJ-28 7 2 46 8.5 2 2 9 34 79.1 10 23.3 34
Microsoft Word - ②（添付資料）家庭の夏期節電実態調査の結果について
CO 2 1. 2012 CO 2 CO 2 CO 2 2. 2012 9 28 10 1 8,241 CO 2 3. (1) 2012 2.7%CO 2 1% 1 2 5.8% 3.7% (2.8%)(2.8%) 6 4 5% 1 3 7 5%3 (2) 2012 32%2011 21 (39%)(38%)(37%) 8 2011 (+17.9 ) (+11.9 )(+9.3 )2012 8 (-14.9
14 00 14 50 3DO3-1 DO3-5 DO3-1 DO3-2 DO3-3 DO3-4 DO3-5 1 1 2 3 3 3 3 3 3 3 1.2. 3. 15 1 2 3 1. 2. 3. 1, 2 2, 3 1, 2 1. 2. JSEPTIC 3. ICU 1 2 1.2. 医 一
第 1 日 目 第 1 日 目 (2 月 9 日 ) 一 演 題 医 師 部 門 演 第 6 会 場 ホテル 日 航 東 京 3F レインボーテラス 9 00 9 50 1 DO1-1 DO1-5 DO1-1 DO1-2 DO1-3 DO1-4 DO1-5 Presepsin LPS PGC-1 1 2 3 2 3 1 1. 2.3. Critical illness polyneuropathy
23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
教室業績2014
Salmonella Agona MRI Noor JI MD : MD-twin score : p- : - : - NEW : - NEW NEW : - : - NEW : - NEW : - NEW : - NEW : - : - : - : - : - : - : - : - : S -S Clinical OB-Gyne : - : S -S : - Sameshima H Ikenoue
10 44 1.2 5 4 5 3 6-1 - 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 10 TEL TEL 1 2 TEL FAX TEL FAX TEL FAX 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 1 2 3 4 5 6 ( ) ( ) 2
() 2
1 () 2 2 4 3 6,500 4 5 2 6 A B A B A B A B - A B 7 8 A B A B A B 9 JR JR 10 11 6 5 12 17 6 13 14 B A A B A B A B 2 1 8 15 8 16 17 9 18 3 4 5 mm mm 19 2 20 3 6 7 11 12 13 14 18 4 3 2 1 21 3 12 13 14 16
幼保連携型認定こども園 教育・保育要領解説
1 1 1 2 1 2 2 5 3 6 4 6 8 8 1 8 2 11 15 1 16 2 17 3 17 4 18 18 23 23 1 24 2 25 3 30 4 30 5 38 6 42 42 45 1 45 2 46 65 65 1 65 2 70 3 71 4 78 5 80 84 1 84 2 87 3 92 4 112 115 1 115 2 120 122 122 124 126
サンプル一覧表.PDF
: 1 30 1 : 1 30 : 8662 60 : 4810 30 1 : 19383 90 : 8872 : 6279 : 7098 180 120 90 : 6405 120 : 7234 :3276 60 280 : 8053 180 : 5512 180 : 4368 100 :4462 120 : 4725 120 : 8851 180 : 3024 180 : 3286 150 :
市区長選挙における民主党の戦略
. , -,,, a, .......................................................... -,,, b b .............................. .. ,. %,,,,, JR TUBE TUBE TUBE TUBE ,. %,,,,,,,,,,,,,,,,,,,, ,. %,,, a, b - - -- pp a b
35 縮小版 和 .indd
2 3 4 5 6 7 8 9 10 11 12 22:46 Co Spd 17.0 kts 23:02 Co Spd 17.0 kts 22:30 Co Spd 8.5 kts 23:02 Co Spd 8.5 kts 22:08 Co Spd 8.0 kts 23:07 Co Spd 8.0 kts 23:02 Co
1 2 2 4 6 6 6 7 7 7 8 8 8 13 15
2014/09/30 1 2 2 4 6 6 6 7 7 7 8 8 8 13 15 40 50 46 40 23 3 11 28 4 4 1 30 6 11 31 5 32 4 7 16 4 22 4 29 30 4 46 12 47 10 56 4 13 12 15 100 20,312 7,609 12,703 3 3,086 723 280 46 47 46 FRP 835 25m11.5m
pp doi: /jjsps.54.6_ The 34th Autumn Symposium of The Japanese Society of Pediatric Surgeons
54 6 2018 10 pp. 1173-1193 doi: 10.11164/jjsps.54.6_1173 1173 34 The 34th Autumn Symposium of The Japanese Society of Pediatric Surgeons 30 2018 10 27 10-1 3-6-2 HP URL https://psjm2018.com/ 34 PSJM2018
’¸’_Ł\”ƒ1-4fiñŒÊ
20 23 2011 1 23 24 10 2010 26 11 20 27 12 29 13 22 35 14 2010 36 15 44 23 3 11 23 27 1 11 46 14 188 14 2 16 22 97 3 2 7 3 30 80 19 22 10 1 37 796 4 3 20 30 30 23 3 30 19 4 1 4 8 1 2 4 5 2010 73 22 7 19
評価結果報告書の概要版（平成20年度）
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76
表紙030313.PDF
H2 CO (1) (3) (4) () () ( ) ( : 11 ) [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]......... [ ] [ ] [ ] [ ] [] [ ] [ ] [ ] [ ] (g) [ ] ) [ ] [ [ ] [ ] [ ] ) ) ) )... [ ] [] [ ] [] [ []........
小児内分泌学会-03-プログラム.indd
10 2 8 30 9 55 SOP 2 P-044 P-045 2 P-046 :Frasier 1 1 1 1 1 1 2 2 1 1 2 P-047 GH 1 1 2 2 2 2 2 1 2 P-048 Bartter 1 1 1 1 2 1 2 P-049 SD IGF-1 GHD P-050-2SD GHD 1 2 2 2 1 2 P-051 GHD 1,2 1 1 1 1 1 2 2 3
リサイクルデータブック2016
AppendixEU SDGs2159EU 21512UNEPOECD2165G7 2165 213 Appendix 1 EU 2 EU 3 215 i CONTENTS i 1 213 1 213 2 1 4 2 2 6 3 3 6 4 213 7 4 5 9 6 213 9 5 7 1 8 213 1 9 11 1 213 11 11 213 11 6 6.1 12 213 14 6.2 13
Microsoft Word - EA21環境活動レポート18.3.31.（5.30..doc
2005 2 15 9 12 1 2 15 3 TEL 03 5755 7031 FAX 03 5755 7036 30 1089.74 1 3 31 2 2004 2006 2 kg-co2 kg 2003 2004 2005 2006 2003 200,117 183,471 181,636 180,105 10 48,150 52,169 48,233.5 44,298 8 331 263 255.625
13 6 2 68 34 JIS S0026 JIS JIS S0026 50000 2550mm 2550mm 2550mm 12 1 4 15 ( ) 3000 1 1 H17 ttp://www.isuzu.co.jp/product/bus/gala_ss/approach.html
<836C83628367834A8374834692B2B895F18145706466>
1. 30 5 500 2 7 100 2 10 100 2007 4 1 7,200 6,800 7 NPO 1,200 1 12 15 2 1.5 0.5 30 2 24 5 27 16.8 28 2.3 10,500 / 3 3,800 117 2 3 6 6,000 1 1 1 2 2006 1 6, 000 + + 8 30 17 00 7.5 13 2 B2 2. 50 2 3 1 1
156 51 1 2015 2 3 6 1 1) 2) 3) 1) 1) 1) 1) 1) 2) 3) 3) 3 1 4 6 2 3 4 Rocky Mountain Soap Rocky Mountain Soap RMS Canmore Banff Pure hand-made 100 toxi
51 1 2015 2 pp. 155-173 155 25 QOL 26 10 18 1993 2000 23 25 3 IT 10 2 end of life living will living will living will 1 NICU QOL NICU QOL 3 6 kg NICU 42 2 kg 2007 NICU 2 NICU/ GCU 25 4 26 3 3 A 156 51
untitled
59 2014 7 12 59 2014 7 12 59 171 3F 2F 1F B2F B3F B2F 1. 2. 3. 1 2 3 9 00 10 00 11 00 9 00 9 30 9 30 9 40 9 40 11 40 9 40 10 50 1 10 50 12 00 D1 1 D1 7 3 D3 1 D3 7 9 40 10 50 2 10 50 12 00 D2 1 D2 7
ml DNA DNA
ml DNA DNA ml PH HO DNADNA DNA LED LED CD CD ch 概 概 mll IC LED OK CD CDDVD CD LED LED LED The LED PVA Part LED LED PPT V LED AI LED V AlCu Fe Al Al PVA ml 概 概 CD CD OHP etc cm PET cm PET cm PET LED LED
天草郡市医師会第139回(臨時)代議員会
A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (
リサイクルデータブック2017
AppendixEU SDGs2159EU 21512UNEPOECD2165G7 2165 214 Appendix 1 EU 2 EU EU( EU EU EU EU 3 217 i CONTENTS i 1 214 1 214 2 1 4 2 2 6 3 3 6 4 214 7 4 5 9 6 214 9 5 7 1 8 214 1 9 11 1 214 11 11 214 11 6 6.1
() 90
1 () 90 15 I 20 20 1 8.5 6.2 AED 17.5 10 9.810 4.5 119 1 119 VF VF 710 CPR 119 119 1 1 3 119 3 180 240 480 24 8 24 16 3 3 1 4 8 119 AED AED 1 8 1 3 1 4 5 3 2 2 AED 3 119 AED 119 AED 119 10 100 30 2 30:2
PSCHG000.PS
FA X IT FA X c c c c cm RSA cprsp c http:w ww.pref.m iyazaki.jpfukushiipeindex.htm l, http:w ww.kenkomap.com m iyazaki Walking Sm oking GDP GDP e f e f e GDP f GDP IT GDP GDP GDP e f GDP GDP GDP
橡Taro10-大豆研究図表込み.PDF
100 t 48 19 12 500 t 1960 28 90 2 3 1960 64 75 15 1987 29-55- 4,386 3,453 825 208 617 9 55 5,017 3,898 945 189 464 89 203 8 70 4,821 3,630 994 196 494 107 197 8 95 4,628 3,426 1,013 193 494 108 218 7 95
w
11 No.469 NOV. 200214 w e r 7 t k k H H y u i Y o !0 Y Y Y Y Y Y!1 1 1!2 !3 a!4 b!5 !6 B 1 1 1 1 b b !7 f 1 1 !8 1 11/ G 1 R u u u u u u u u u u u u ub u u u u u uc u u u u s s s s s s s s sb s s!9 c Y
PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3
1 9 2017-05-06 Marie Spano, MS, RD 185 AND CSSD 2 9 2017-05-06 PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3 3 136 EPA D 46 B12 B12 B12 2010 98
本文01id5.indd
1 TFT 9F 906 907 907 1 TFT 9F 906 90 1 P1-01 P1-02 1 1 1 2 1 1 2 P1-03 P1-04 P1-05 4 P1-06 P1-07 P1-08 1 1 1 2 1 2 P1-09 VCM TDM VCM 1 2 2 2 3 3 4 5 1 2 3 4 5 2 P2-01 P2-02 P2-03 83 1 TFT 9F 906 907 906
10 2 2 10 6.5 78 1 65 / 30 / - 2 -
- 1 - 10 2 2 10 6.5 78 1 65 / 30 / - 2 - 3 3 30 8 4 8 6 11 14 45 14 7 8 1-3 - 4 1 () 20 4 9 4 9 3 9 4 PR 4 3-4 - - 5 - PR 15 4 PR 7 8 4 9 10-6 - 9 10 9 10 4 9 10 3 9 10 9 9 9 10 PR 1-7 - PR - 8 - 30 100-9
General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2)
General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2) (3) (4) (Standard Precautions ) (5) ( ) (6) (7) ( ) ( ) QOL(Quality of Life) ( ) (8) 1 2 (1) (2) (3) 4 24 (4) 3 ABC3 (common
2
5 15.8% 17.1% 13.7% 15 1 34.0%3 1 3 25.7 4 1 76.5 3.3 2 23 3225 36 72.0 13.3 1 26 38 ( 77.8 87.8 69.5 2010 3 20 60 7 20 2 3 1 2 ( 77.8 87.8 69.5 2010 87.9 66.5 3 20 83.030 92.240 93.6 50 91.660 6065 72.9
長崎県県央保健所事業概要
P1 P2~P3 P4 P5 P7~P10 P11~P40 P41~P174 P175~P179 P181~P212 271,417 2 3 4 5 5 7 8 9 10 12 13 14 15 16 18 19 2,506 365 293 5 20 2 4 123 4 17 1 2 143 351 5 3 18 40 10 475 3 2 22 22 66 1 13 18 31 10
untitled
28 20 1 31 4 2 25 1 IgG IgA IgM IgE IgM 2 60 80 70 60 60 40 20 80 35 45 kg 150cc 100 120cc 100cc 30 40cc 7,000g 500cc 120cc 120 5=600cc 600g 30 2,100cc 1,000cc 3 4 14 5 6 7 8 9 10 11 12 SIDS SIDS SIDS
67.5km 299.4km 2 2 2 16km 1/6 47km 2 1 1 (m) (km 2 ) 2,700 7.6 9,927 47.1 8,100 13.4 8,120 4.8 52 0.4 1,100 6.0 2,200 3.8 6,982 45.3 4,473 14.4 5,000 9.5 2 (km 2 ) (km) 1 299.4 67.5 2 284.5 38.8 3 267.0
untitled
20 7 1 22 7 1 1 2 3 7 8 9 10 11 13 14 15 17 18 19 21 22 - 1 - - 2 - - 3 - - 4 - 50 200 50 200-5 - 50 200 50 200 50 200 - 6 - - 7 - () - 8 - (XY) - 9 - 112-10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 -
untitled
19 1 19 19 3 8 1 19 1 61 2 479 1965 64 1237 148 1272 58 183 X 1 X 2 12 2 15 A B 5 18 B 29 X 1 12 10 31 A 1 58 Y B 14 1 25 3 31 1 5 5 15 Y B 1 232 Y B 1 4235 14 11 8 5350 2409 X 1 15 10 10 B Y Y 2 X 1 X
救急車同乗実習レポート 総括
14 9 1 9 10 10 19:00 23:00 52 1 6.5 40 CT X CT Ope 15 /min BP 100/70mmHg HR 96 /min O U m 60 25/min BP 140/80mmHg HR 55 O Spo 98 BP 172/68mmHg O 30 15 /min BP 100/60mmHg HR 80 /min BS O O CO 30 40 JCS
日本医師会雑誌第131巻第10号
B C 100 12 11 13 3 C 4 C Q&A B C 54 B B B B Q&A B B HBV 20 HBV B B B B HBV HBV HBV HBV 2 HBV HBV HBV A HBV HBV HBV HBV HBV Q37 HBV HBV HBV 1015 B B B Q51 B HBV B B HBV B HBV HBV HBV B B B HBV B HBV HBV
2004 10 2004 1984 2 1986 4 20 60 1 3 1 1 1 13,300 2 2 2 3 1 2004 2009 2 1 1 2 1 1985 97JR JT NTT 2002 96 97 4 JR JT 97 3 JR 19 29 JT 2.4 2.5 JR JT NTT JR JT NTT 2 97 4 JR 20.09 JT 19.92 NTT 17.35 17.35
89 91 93 95 97 99 101 103 105 107 109 111 113 115 H 117 119 l l 121 l l 123 125 127 129 l l l l 131 kl kl kl kl 133 135 137 139 141 143 145 147 149 151 153 155 157 159
株式会社日清製粉グループ本社 第158期中間事業報告書
C O N T E N T S...1...3...5...7...9...11...12...13...14 1 2 3 4 3.7% 5.8% 8.5% 70,100kL 81.2% 0.8% 25 20 15 10 5 0 9.18 9.54 9.74 9.62 9.65 9.71 21.04 21.97 22.44 22.23 8.54 22.31 22.45 20.41 15 12 9 6
1. 3 2. 2 7 3. 10 4. 12 5. 15 6. 18 7. 21 8. 24 9. 28 10. 31 11. 34 12. 38 13. 41 14. 44 15. 47-1 - 16. LET S TRY 50 17. 52 18. 55 19. K 58 20. TAWASHI 62 21. 65 22. 68 23. 72 24. Student Venture Project
2001 2003 2005 2006 2007 2008
2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65
０４００９０８ｦ医大ニュース８０／医大ニュース第８０号ＰＤＦ
2004 8 80 1 No.80 2004.8 TEL FAX 15 3 24 105 15 5 3 5 14 4 99 67 51 16 16 4 6 100 90 3 15 6 4 7 72 4 5 30 15 15 15 H16.3.24 16 H16.4.6 15 H16.3.5 2 2004 8 80 54 1979 4 25 56 20 1500 10 5cm 1 500 10 50
A A
3 A B C A A 2 5 1 62 A 1 1 2 63 3 1 A proven invasive fungal diseases 1 2 3 BAL 24 : Fusarium spp. 4 2 : Candida Trichosporon B probable invasive fungal diseases Cpossible invasive fungal diseases 5 1
Core Ethics Vol. : - NICU : : - A B C D
Core Ethics Vol.,NMR...... Core Ethics Vol. : - NICU : : - A B C D b: Duff and Campbell A B C: D : a B C b Core Ethics Vol. : -, : C D :.. D.. bd D CD AB CD : Duff C b C B : Core Ethics Vol. C D B A D
41-6_50回中国地方会Pr6N__HP掲載用.indd
2014 9 6 1, 2, 2, 2, 2 1, 2 60.. CT S 5 47 mm, 20 mm. US,,..,,. CT.,,.,. 8.,,.,. 1, 2, 2, 2, 2, 2, 3, 3 1, 2, 3 70 5,, CT. 17, 20, 30..,. Segmental Arterial Mediolysis SAM,.,. SAM,., 50,.,, 70. S 5 SOL.
PowerPoint プレゼンテーション
0 1 2 3 4 5 6 1964 1978 7 0.0015+0.013 8 1 π 2 2 2 1 2 2 ( r 1 + r3 ) + π ( r2 + r3 ) 2 = +1,2100 9 10 11 1.9m 3 0.64m 3 12 13 14 15 16 17 () 0.095% 0.019% 1.29% (0.348%) 0.024% 0.0048% 0.32% (0.0864%)
23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979
抄録_46回中国地方会37-6_責.indd
46 22 9 11 Update 46-1 Gd-EOB-DTPA MRI EOB-MRI HCC dysplastic nodule DN 146 62 146 123 HCC 23 DN B hypoechoic 67 46%hyperechoic 79 54% bright loop 14% A dynamic MDCT iso density EOB-MRI 24 B CT low density
051
June THE JAPANESE JOURNAL OF ANTIBIOTICS 57 3 295( 83 ) NTT 1. 2. 3. 4. CHOP-R 5. DNA 1 296( 84 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 57 3 June 3 1 2003 10 4 1 NTT June THE JAPANESE JOURNAL OF ANTIBIOTICS
…GŒÆ›u››‘KŒâ‚è_cs1.indd
1 1-1 4 1-2 a. b. c. d. e. 1-3 A. 4 B. 3 1-4 a. b. c. d. e. 1-5 1-6 4 1-7 a. b. c. d. e. 1-8 a. b. c. d. e. 1-9 1-10 A. 2 B. C. 1-11 a. / 2 b. / c. / d. / e. / 1-12 a. T b. c. M d. e. 1-13 1-14 1-15 16
名称未設定-2
Contents 1 2 3 4 5 6 7 8 9 1 11 12 13 14 15 16 17 18 19 2 21 22 i 23 24 25 26 27 28 29 3 31 32 33 34 35 36 37 38 39 4 41 42 43 44 45 46 47 48 49 5 51 52 53 54 55 56 57 ii 58 59 6 61 62 63 64 65 66 67 68
01-3 目次 .xls
119 6 (170 ) 5 4 3 2 1 F F WC -1-2 -1-2 C C A P D 612 (1B) 613 (1B) 615 (1B) 616 (1B) 617 4B 611 B 610 B 608 B 607 B 606 B 605 B 603 B 602 B 601 (1B) 512 (1B) 513 (1B) 515 (1B) 516 (1B) 517 4B 518 (1B)
001 No.3/12 1 1 2 3 4 5 6 4 8 13 27 33 39 001 No.3/12 4 001 No.3/12 5 001 No.3/12 6 001 No.3/12 7 001 8 No.3/12 001 No.3/12 9 001 10 No.3/12 001 No.3/12 11 Index 1 2 3 14 18 21 001 No.3/12 14 001 No.3/12
ml ml ~ml : ml
ml ml ~ml : ml , ) RI CT MRI( MRI (T2T1 MRI MR Mokri Mokri Mokri ICHD-II) Schievink post-lumbar puncture headache) 1938 Schaltenbrand spontaneous aliquorrhea( 1958 Shenkinlow cerebral spinal fluid pressure
4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2
5 2006 9 1 A) 1 2 3 4 B) 1 2 3 4 5 2 A) GDP 7.9 B) 31 25 8 10 1 45 3 31 8 2 70 1 4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 1.6 3 31.1 4 2 5 3 4 CT MRI PET 1 30 A) 1 2 6 B) 1 2 3 4 5 3 90.5
